Additional analysis of the data combined with the clinicopathological characteristics revealed that in patients with NTN4 low expression of ccRCC, the death rate was higher if the corresponding patient was older or had a higher-grade stage pathology. This evidence concerns the gene NTN4 and nonpapillary renal cell carcinoma.